Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi T Mehta

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Eye (London, England)|September 29, 2020
Hydroxychloroquine retinopathy-less than meets the eyeAnil Pareek, S Chandrashekara, Ravi T Mehta
Annals of the Rheumatic Diseases|October 15, 2017
Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV riskAnil Pareek, Indranil Purkait, Ravi T Mehta, et al.
JACC. Heart Failure|November 4, 2017
Diabetic Hypertensives and Diastolic Dysfunction: Use of Calcium Channel Blockers-A Clinical ConcernAnil K Pareek, Ravi T Mehta, Indranil Purkait, et al.
Journal of the American College of Cardiology|September 15, 2018
Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective TargetingAnil K Pareek, Franz H Messerli, Ravi T Mehta, et al.
The Lancet. Global Health|January 26, 2020
Optimising TRIUMPH with 6·25 mg chlorthalidoneAnil Pareek, C Venkata S Ram, Ravi T Mehta, et al.
Journal of Hypertension|October 7, 2020
2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidenceAnil Pareek, C Venkata S Ram, Shashank Joshi, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 15, 2024
Efficacy and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in persistent asthma: Phase 3 OD-INHALE StudyAvdhesh Kumar, Manish Kumar Jain, Vijaykumar Bhagwan Barge, et al.
Clinical Drug Investigation|January 10, 2024
A Real-World Observational Study to Evaluate the Safety and Effectiveness of Fluticasone Furoate-Oxymetazoline Fixed Dose Combination Nasal Spray in Patients with Allergic RhinitisMeenesh R Juvekar, Gauri Kapre Vaidya, Aniruddha Majumder, et al.
Asia Pacific Allergy|December 5, 2025
Diagnosis and management of allergic rhinitis: An Indian expert consensus by otorhinolaryngologistsMohan Kameswaran, Meenesh Juvekar, Deepak Haldipur, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Eye (London, England)|September 29, 2020
Hydroxychloroquine retinopathy-less than meets the eyeAnil Pareek, S Chandrashekara, Ravi T Mehta
Annals of the Rheumatic Diseases|October 15, 2017
Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV riskAnil Pareek, Indranil Purkait, Ravi T Mehta, et al.
JACC. Heart Failure|November 4, 2017
Diabetic Hypertensives and Diastolic Dysfunction: Use of Calcium Channel Blockers-A Clinical ConcernAnil K Pareek, Ravi T Mehta, Indranil Purkait, et al.
Journal of the American College of Cardiology|September 15, 2018
Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective TargetingAnil K Pareek, Franz H Messerli, Ravi T Mehta, et al.
The Lancet. Global Health|January 26, 2020
Optimising TRIUMPH with 6·25 mg chlorthalidoneAnil Pareek, C Venkata S Ram, Ravi T Mehta, et al.
Journal of Hypertension|October 7, 2020
2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidenceAnil Pareek, C Venkata S Ram, Shashank Joshi, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 15, 2024
Efficacy and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in persistent asthma: Phase 3 OD-INHALE StudyAvdhesh Kumar, Manish Kumar Jain, Vijaykumar Bhagwan Barge, et al.
Clinical Drug Investigation|January 10, 2024
A Real-World Observational Study to Evaluate the Safety and Effectiveness of Fluticasone Furoate-Oxymetazoline Fixed Dose Combination Nasal Spray in Patients with Allergic RhinitisMeenesh R Juvekar, Gauri Kapre Vaidya, Aniruddha Majumder, et al.
Asia Pacific Allergy|December 5, 2025
Diagnosis and management of allergic rhinitis: An Indian expert consensus by otorhinolaryngologistsMohan Kameswaran, Meenesh Juvekar, Deepak Haldipur, et al.
Pageof 1